Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
1.34T | 1.31T | 1.33T | 1.13T | 995.94B | 1.04T | Gross Profit |
468.88B | 456.67B | 450.76B | 418.45B | 352.38B | 362.00B | EBIT |
71.59B | 64.72B | 95.11B | 89.64B | 61.64B | 40.86B | EBITDA |
136.76B | 141.49B | 163.80B | 154.23B | 118.92B | 110.28B | Net Income Common Stockholders |
51.59B | 52.62B | 75.04B | 92.29B | 30.92B | 7.73B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
170.25B | 330.48B | 267.38B | 335.24B | 304.01B | 196.26B | Total Assets |
1.03T | 1.41T | 1.34T | 1.27T | 1.16T | 1.04T | Total Debt |
144.79B | 204.78B | 233.28B | 243.15B | 265.91B | 209.68B | Net Debt |
-23.62B | -328.48B | 6.40B | 2.01B | 13.69B | 13.42B | Total Liabilities |
494.74B | 601.96B | 614.10B | 600.68B | 608.36B | 534.87B | Stockholders Equity |
532.95B | 810.99B | 727.35B | 665.63B | 550.92B | 503.75B |
Cash Flow | Free Cash Flow | ||||
116.98B | 108.98B | 2.21B | 66.96B | 77.35B | 26.62B | Operating Cash Flow |
173.58B | 165.57B | 61.31B | 110.80B | 133.22B | 102.32B | Investing Cash Flow |
-57.77B | -58.98B | -61.60B | -44.08B | -57.45B | -76.13B | Financing Cash Flow |
-65.01B | -65.39B | -79.35B | -51.77B | 23.15B | -283.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $4.82B | ― | -6.32% | ― | -28.33% | -129.75% | |
68 Neutral | $5.12B | 13.84 | 6.98% | 2.04% | -6.04% | -5.40% | |
64 Neutral | $4.05B | 20.17 | 8.17% | ― | 0.94% | -60.23% | |
57 Neutral | $20.94B | 10.43 | -13.41% | 2.52% | 4.53% | -23.34% | |
53 Neutral | $3.71B | ― | -16.69% | ― | -25.29% | -449.44% | |
52 Neutral | $3.00B | ― | -37.33% | ― | 19.52% | 24.03% | |
50 Neutral | $3.02B | ― | -137.83% | ― | 4.66% | 84.78% |